A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury

reportActive / Technical Report | Accession Number: ADA458219 | Open PDF

Abstract:

The overarching goal of this project is to study the effects of a serotonin reuptake inhibitor SRI citalopram for the treatment of anxiety experienced by individuals after traumatic brain injury TBI. Specifically this project seeks to treat individuals who meet criteria for DSM-IV diagnosis of Anxiety Disorder Due to a General Medical Condition within 6 to 24 months of TBI. A randomized placebo controlled design with i-year follow-up will be utilized to evaluate the effectiveness of citalopram in alleviating significant anxiety symptoms that cause significant distress and can lead to medical retirement of active duty soldiers

Author(s):
Warden, Deborah L.
Author Organization(s):
HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE ROCKVILLE MD
Descriptive Note:
Annual rept. 1 Apr 2005-31 Mar 2006
Supplementary Note:
The original document contains color images. DOI: 10.21236/ADA458219
Pagination:
0006

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release; Distribution Is Unlimited.

RECORD

Collection: TR
Identifying Numbers
Contract/Grant Number(s):
DAMD17-03-2-0028
Monitor Series:
USAMRMC
 Subject Terms
Joint Capability Areas:
JCA_1.4_Force Support; JCA_1.4.1_Force Health Protection; JCA_5_Command and Control; JCA_6_Net Centric; JCA_1.2.5_Lessons Learned; JCA_6.1_Information Transport; JCA_8_Building Partnerships
Communities of Interest:
No COI(s) Identified
Descriptor(s):
*BRAIN, *ORDER DISORDER TRANSFORMATIONS, *ANXIETY, *WOUNDS AND INJURIES, *MENTAL DISORDERS, RANDOM VARIABLES, PLACEBOS, TRAUMA
Field(s)/Group(s):
Psychology, Anatomy and Physiology
Report Date:
2006 Apr 01
Creation Date:
2006 Dec 20